Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A081105 Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) |
|---|---|
| Full Title | A081105 Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) |
| Disease/Condition | Medical and Hematologic Oncology |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Haiying Cheng |
| Contact Name | Daniel Paucar |
| Contact Email | dpaucar@montefiore.org |
| Protocol Number | IRB# 2016-7052 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
